Government of Canada investing $24 million to establish Canada’s first national cannabis …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchMental HealthSafetyPediatricsAnxietyDosing Why This Matters Clinicians need evidence-based guidance on…
CBD locks onto a key MS (Multiple Sclerosis) inflammation protein more stably than a …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CBDNeurologyResearchSafetyMental HealthHempAnxiety Why This Matters Cannabidiol (CBD) may offer a new therapeutic avenue…
CDC: Cannabis Hyperemesis Syndrome ER Visits Jump After New Diagnosis Code
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. SafetyResearchPediatricsNeurologyMental HealthPolicyTHC Why This Matters Clinicians need to recognize that Cannabis…
Colorado Study Tests Cannabis Driving Effects in Adults 65 and Older
The Colorado older adults cannabis driving study is testing simulated driving and cognition after inhaled cannabis. Researchers are still collecting data, so the project has not established a safe waiting period. Here is what older patients, families,…
CBD Topicals and Nerve Pain: What Current Research Says and What Consumers Should Know
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CBDPainResearchNeurologySafetyDosingHemp Why This Matters Clinicians need to understand the emerging evidence on CBD…
THC Medication Eliminates PTSD Nightmares for a Third of Patients
A clinical trial of THC medication PTSD nightmares clinical trial results shows that about one-third of patients experienced significant nightmare reduction. This emerging treatment offers hope for those with PTSD nightmares resistant to standard…
Cannabis, nicotine led US adult substance use trends in 2025
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchPolicySafetyMental HealthTHCIndustryPain Why This Matters Clinicians need to recognize that cannabis and nicotine…
Little Green Pharma (ASX:LGP): Medical Cannabis Expansion Trends to Watch
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDPainAnxietyPolicySafetyIndustry Why This Matters Clinicians need to monitor cannabis sector developments…
Clinical Trial: Plant-Derived Cannabis Preparation Is Safe and Effective in Children with Autism
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchSafetyPediatricsNeurologyMental HealthCBDAnxiety Why This Matters Clinicians treating children with autism…
Artelo Announces Enrollment of First Patient in a Phase 2 Clinical Trial Evaluating ART27.13 …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchSafetyNeurologyCBDTHCDosingIndustry Why This Matters This Phase 2 trial evaluating ART27.13 for intraocular…